| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,688,000 | 17,154,000 | 16,502,000 | 12,664,000 | | Cost of Revenue | 14,438,000 | 13,717,000 | 13,745,000 | 11,437,000 | | | Gross Profit | 2,250,000 | 3,437,000 | 2,757,000 | 1,227,000 | | | Operating Expenses | | Research Development | 3,574,000 | 960,000 | 970,000 | 957,000 | | Selling General and Administrative | 868,000 | 957,000 | 759,000 | 734,000 | | Non Recurring | (83,000) | (99,000) | 3,000 | 193,000 | | Others |
-
|
-
|
-
| (241,000) | | | | Total Operating Expenses |
-
|
-
|
-
| 1,643,000 | | | | Operating Income or Loss | (2,109,000) | 1,619,000 | 1,025,000 | (416,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,000) | 47,000 | (36,000) | (10,000) | | Earnings Before Interest And Taxes | (2,113,000) | 1,666,000 | 989,000 | (426,000) | | Interest Expense | 134,000 | 170,000 | 57,000 | (116,000) | | Income Before Tax | (2,247,000) | 1,496,000 | 932,000 | (310,000) | | Income Tax Expense | (687,000) | 499,000 | 317,000 | (224,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,560,000) | 997,000 | 615,000 | (86,000) | | | Non-recurring Events | | Discontinued Operations | (4,000) | 1,000 | (5,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,564,000) | 998,000 | 610,000 | (86,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,564,000) | $998,000 | $610,000 | ($86,000) |
|
1.48% Nasdaq 
Income Statement
